<DOC>
	<DOCNO>NCT01440309</DOCNO>
	<brief_summary>The study design evaluate safety efficacy intravenous administration bone marrow derive mesenchymal stem cell patient refractory primary biliary cirrhosis ( PBC ) .</brief_summary>
	<brief_title>Efficacy Safety Study Allogenic Mesenchymal Stem Cells Patients With Refractory Primary Biliary Cirrhosis</brief_title>
	<detailed_description>Primary biliary cirrhosis ( PBC ) organ-specific inflammatory disease characterize immune mediate destruction intrahepatic bile duct , lead liver cirrhosis eventually failure.Currently , ursodeoxycholic acid ( UDCA ) drug approve Food Drug Administration ( FDA ) . Novel treatment urgently need patient incomplete response UDCA . Mesenchymal stem cell ( MSC ) represent promise tool cell-based therapy autoimmune disease . To explore therapeutic effect MSCs PBC , investigator plan conduct open-label , randomized clinical trial . Patients PBC enrol randomly divide two group receive MSCs UDCA respectively . The investigator evaluate efficacy safety MSCs PBC comparison symptom improvement , survival rate side effect two group .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Cirrhosis , Biliary</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>There must least two follow : concentration serum AMAs titres 1:40 high ; unexplained rise amount alkaline phosphatase least 1•5 time upper limit normal 24 week ; compatible liver histological finding , specifically nonsuppurative cholangitis interlobular bile duct injury . Incomplete response UDCA 1315 mg/kg/day , Criteria group complete responder include : concentration alkaline phosphatase less three time upper limit normal , aspartate aminotransferase less twice upper limit normal , bilirubin less 17 μmol/L ; normalisation abnormal concentration bilirubin , albumin , . Liver pathological stag 2 or3 , Histological stag base Ludwig 's Scheuer 's classification Patients receive investigational agent within 4 week study entry Uncontrolled intercurrent illness include , limited , ongoing active infection ( defined invasive fungal infection progressive CMV viremia ) , symptomatic congestive heart failure ( NYH class III IV ) , unstable angina pectoris , cardiac arrhythmia In pregnancy lactation Psychiatric illness mental deficiency make compliance treatment inform consent impossible HCVpositive ，HBSAg positive liver disease Combined autoimmune disease Expected survival time le one year Decompensation liver function（Child B C） Have history allergy Allergic constitution</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>biliary cirrhosis</keyword>
</DOC>